CS logo
small CS logo
IRCCS Ospedale Casa Sollievo Della Sofferenza; Oncologia

San Giovanni Rotondo, Puglia, Italy

About IRCCS Ospedale Casa Sollievo Della Sofferenza; Oncologia


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
No rows

Clinical Trials at IRCCS Ospedale Casa Sollievo Della Sofferenza; Oncologia


During the past decade, IRCCS Ospedale Casa Sollievo Della Sofferenza; Oncologia conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 6 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
No rows

Rows per page:

0–0 of 0

Clinical Trials Sponsors and Collaborators


Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at IRCCS Ospedale Casa Sollievo Della Sofferenza; Oncologia


According to Clinical.Site data, the most researched conditions in "IRCCS Ospedale Casa Sollievo Della Sofferenza; Oncologia" are "Colorectal Cancer" (2 trials), "Bladder Cancer" (1 trials), "Breast Cancer" (1 trials), "Breast Neoplasms" (1 trials) and "Carcinoma, Hepatocellular" (1 trials). Many other conditions were trialed in "IRCCS Ospedale Casa Sollievo Della Sofferenza; Oncologia" in a lesser frequency.

Clinical Trials Intervention Types at IRCCS Ospedale Casa Sollievo Della Sofferenza; Oncologia


Most popular intervention types in "IRCCS Ospedale Casa Sollievo Della Sofferenza; Oncologia" are "Drug" (10 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Atezolizumab" (5 trials), "Bevacizumab" (2 trials), "Carboplatin" (2 trials), "Cobimetinib" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

Clinical Trials Genders at IRCCS Ospedale Casa Sollievo Della Sofferenza; Oncologia


The vast majority of trials in "IRCCS Ospedale Casa Sollievo Della Sofferenza; Oncologia" are 9 trials for "All" genders and 1 trials for "Male" genders.

Clinical Trials Status at IRCCS Ospedale Casa Sollievo Della Sofferenza; Oncologia


Currently, there are NaN active trials in "IRCCS Ospedale Casa Sollievo Della Sofferenza; Oncologia". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in IRCCS Ospedale Casa Sollievo Della Sofferenza; Oncologia, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in IRCCS Ospedale Casa Sollievo Della Sofferenza; Oncologia, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status